Applied Visual Sciences, Inc. (APVS)
For informational purposes only. Not financial advice. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Applied Visual Sciences, Inc. (APVS) with AI Score 44/100 (Weak). Applied Visual Sciences, Inc. specializes in computer-vision detection solutions for aviation/homeland security and healthcare. Market cap: 0, Sector: Technology.
Last analyzed: Mar 16, 2026Applied Visual Sciences, Inc. (APVS) Technology Profile & Competitive Position
Applied Visual Sciences, Inc. develops computer-vision solutions for aviation security and healthcare, focusing on automated threat recognition and diagnostic imaging. Their Signature Mapping platform and PinPoint technology target critical needs in security and medical sectors, operating in a competitive software application landscape.
Investment Thesis
Applied Visual Sciences, Inc. operates in niche markets within the security and healthcare sectors, leveraging computer-vision technology. With a market capitalization of $0.00B and a negative P/E ratio of -0.01, the company's financial performance is currently challenged. The company's beta of -10.35 suggests high volatility relative to the market. Growth catalysts depend on successful commercialization of their Signature Mapping platform and PinPoint technology. Key risks include limited financial resources, intense competition, and the need for regulatory approvals. Investors should closely monitor the company's ability to secure contracts and expand its market presence.
Based on FMP financials and quantitative analysis
Key Highlights
- Market Cap: $0.00B indicating a micro-cap company with limited financial resources.
- P/E Ratio: -0.01 reflecting negative earnings and potential financial instability.
- Beta: -10.35 suggesting high volatility and potential for significant price swings.
- Dividend Yield: None indicating no current income for investors.
- Focus on computer-vision detection solutions for aviation/homeland security and healthcare markets, positioning them in high-growth sectors.
Competitors & Peers
Strengths
- Proprietary computer-vision technology.
- Focus on high-growth markets (security and healthcare).
- Established Signature Mapping platform.
- Specialized expertise in target recognition and diagnostic imaging.
Weaknesses
- Limited financial resources.
- Small employee base (3 employees).
- Dependence on a few key products.
- Negative P/E ratio indicating unprofitability.
Catalysts
- Ongoing: Potential contracts with airports for PinPoint technology.
- Ongoing: Adoption of Signature Mapping platform in healthcare.
- Upcoming: Potential strategic partnerships with industry players.
- Upcoming: Securing government contracts for homeland security applications.
Risks
- Ongoing: Limited financial resources.
- Potential: Intense competition from larger companies.
- Potential: Rapid technological advancements.
- Potential: Regulatory hurdles and compliance requirements.
- Ongoing: Low trading volume and liquidity due to OTC listing.
Growth Opportunities
- Expansion in Aviation Security: The increasing need for enhanced security measures at airports globally presents a significant growth opportunity for APVS's PinPoint technology. The market for aviation security systems is projected to reach billions of dollars by 2030. Securing contracts with major airports could drive substantial revenue growth for APVS.
- Adoption in Healthcare Diagnostics: The Signature Mapping platform has the potential to revolutionize diagnostic radiology and pathology. As healthcare providers increasingly adopt AI-powered diagnostic tools, APVS can capitalize on the growing demand for accurate and efficient detection systems. The market for AI in healthcare diagnostics is expected to grow rapidly over the next decade.
- Strategic Partnerships: Forming strategic alliances with established players in the security and healthcare industries can accelerate market penetration for APVS. Partnering with companies that have existing distribution channels and customer relationships can provide access to new markets and customers.
- Government Contracts: Securing government contracts for homeland security applications can provide a stable revenue stream for APVS. Government agencies are increasingly investing in advanced security technologies to protect critical infrastructure and public spaces. APVS's PinPoint technology is well-suited for these applications.
- International Expansion: Expanding into international markets can unlock new growth opportunities for APVS. The demand for advanced security and healthcare solutions is growing globally, particularly in emerging markets. Adapting its products to meet the specific needs of different regions can drive international sales.
Opportunities
- Expansion into new geographic markets.
- Strategic partnerships with industry leaders.
- Securing government contracts.
- Adoption of AI in healthcare diagnostics.
Threats
- Intense competition from larger companies.
- Rapid technological advancements.
- Regulatory hurdles and compliance requirements.
- Economic downturn affecting customer spending.
Competitive Advantages
- Proprietary computer-vision algorithms.
- Patented Signature Mapping platform technology.
- Specialized expertise in aviation security and healthcare diagnostics.
- Established relationships with key customers and partners.
About APVS
Founded in 1989 and based in Leesburg, Virginia, Applied Visual Sciences, Inc. (APVS) is a software technology company specializing in computer-vision detection solutions. Originally named Guardian Technologies International, Inc., the company rebranded in July 2010 to reflect its focus on advanced visual technologies. APVS designs and develops integrated information management technology products and services for corporations and governmental agencies, primarily targeting the aviation/homeland security and healthcare markets. Their core offerings include PinPoint, an intelligent computer-vision system for automated target recognition of threats like guns and explosives in baggage and building security. Additionally, APVS provides the Signature Mapping platform technology, which is used in diagnostic radiology and pathology. This platform underpins the Signature Mapping Detection System, a hardware-software solution for infectious disease applications, and specific software like Signature Mapping Tuberculosis Detection and Signature Mapping Breast Cancer Detection. APVS markets its products globally through direct sales and indirect distribution channels.
What They Do
- Develop computer-vision detection solutions.
- Design software for aviation/homeland security.
- Create imaging technologies for healthcare markets.
- Offer PinPoint technology for threat detection.
- Provide Signature Mapping platform for diagnostic radiology.
- Offer Signature Mapping Detection System for infectious disease applications.
Business Model
- Direct sales of software and hardware solutions.
- Indirect distribution through channel partners.
- Licensing of Signature Mapping platform technology.
- Service and maintenance contracts for installed systems.
Industry Context
Applied Visual Sciences, Inc. operates in the software application industry, which is characterized by rapid technological advancements and intense competition. The market for computer-vision solutions in security and healthcare is growing, driven by increasing demand for automated threat detection and diagnostic accuracy. Key competitors include companies offering similar imaging and detection technologies. APVS's success depends on its ability to innovate and differentiate its products in this competitive landscape.
Key Customers
- Airports and transportation security agencies.
- Hospitals and diagnostic imaging centers.
- Government agencies focused on homeland security.
- Research institutions studying infectious diseases.
Financials
Chart & Info
Applied Visual Sciences, Inc. (APVS) stock price: Price data unavailable
Latest News
-
Comparing Applied Visual Sciences (OTCMKTS:APVS) & Axon Enterprise (NASDAQ:AXON)
defenseworld.net · Mar 10, 2026
Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for APVS.
Price Targets
Wall Street price target analysis for APVS.
MoonshotScore
What does this score mean?
The MoonshotScore rates APVS's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: William J. Donovan
CEO
William J. Donovan serves as the CEO of Applied Visual Sciences, Inc., overseeing the company's strategic direction and operations. With a focus on leveraging technology for security and healthcare applications, Donovan manages a small team of 3 employees. His background likely includes experience in technology management and business development. Further details on his specific career history and educational credentials are not available.
Track Record: Given the limited information available, it is difficult to assess William J. Donovan's specific track record at Applied Visual Sciences, Inc. However, as CEO, he is responsible for guiding the company's product development, market expansion, and financial performance. The success of APVS's Signature Mapping platform and PinPoint technology will be key indicators of his leadership.
APVS OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Applied Visual Sciences, Inc. may not meet the minimum financial standards or disclosure requirements for higher tiers like OTCQX or OTCQB. Companies in this tier often have limited trading volume and may not be required to provide regular financial reports. Unlike companies listed on major exchanges like the NYSE or NASDAQ, OTC Other companies face fewer regulatory requirements, which can increase investment risk.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited financial disclosure.
- Low trading volume and liquidity.
- Potential for price manipulation.
- Higher risk of fraud or mismanagement.
- Lack of regulatory oversight.
- Verify the company's financial statements.
- Assess the company's business model and competitive position.
- Research the background of the company's management team.
- Evaluate the company's regulatory compliance.
- Understand the risks associated with investing in OTC stocks.
- Check for any legal or regulatory actions against the company.
- Determine the company's ownership structure.
- Longevity in the market (founded in 1989).
- Focus on specialized technology solutions.
- Patented Signature Mapping platform technology.
- Targeting high-growth markets (security and healthcare).
APVS Technology Stock FAQ
What does Applied Visual Sciences, Inc. do?
Applied Visual Sciences, Inc. (APVS) is a technology company that specializes in developing computer-vision detection solutions. Their primary focus is on creating and marketing technologies for the aviation/homeland security and healthcare markets. Their flagship products include PinPoint, designed for automated threat recognition in security environments, and the Signature Mapping platform, which is used in diagnostic radiology and pathology. APVS aims to provide integrated information management solutions to corporations and government agencies, addressing critical needs in security and medical sectors.
What do analysts say about APVS stock?
As of 2026-03-16, there is no available analyst coverage for Applied Visual Sciences, Inc. This lack of coverage is likely due to the company's small market capitalization ($0.00B) and its listing on the OTC market. Investors should conduct their own thorough research and due diligence before investing in APVS, considering the limited information available and the risks associated with OTC stocks. Key valuation metrics include the negative P/E ratio (-0.01) and the volatile beta (-10.35).
What are the main risks for APVS?
Investing in Applied Visual Sciences, Inc. carries several significant risks. The company's limited financial resources and small employee base (3 employees) pose challenges to its ability to compete effectively. The OTC listing results in low trading volume and liquidity, increasing price volatility. Additionally, rapid technological advancements and intense competition in the software industry could threaten APVS's market position. Regulatory hurdles and compliance requirements in the security and healthcare sectors also present ongoing risks.
What are the key factors to evaluate for APVS?
Applied Visual Sciences, Inc. (APVS) currently holds an AI score of 44/100, indicating low score. Key strength: Proprietary computer-vision technology.. Primary risk to monitor: Ongoing: Limited financial resources.. This is not financial advice.
How frequently does APVS data refresh on this page?
APVS prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.
What has driven APVS's recent stock price performance?
Recent price movement in Applied Visual Sciences, Inc. (APVS) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Proprietary computer-vision technology.. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.
Should investors consider APVS overvalued or undervalued right now?
Determining whether Applied Visual Sciences, Inc. (APVS) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.
What research should beginners do before buying APVS?
Before investing in Applied Visual Sciences, Inc. (APVS), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Limited information available on the company's financials and operations.
- OTC listing increases investment risk.
- AI analysis pending for APVS.